 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 16, 2020 GLOBE NEWSWIRE -- Merus N.V. Nasdaq:MRUS, a clinical-stage oncology company developing innovative, full-length multispecific antibodies Biclonics and TriclonicsTM, today announced that Bill Lundberg, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 at 14:40 p.m. GMT9:40 a.m. ET. 